Marijke Becx-Bleumink
Volume:
61 - Edition:
1 -
Jan/Feb/Mar -
1993
Priorities for the future and prospects for leprosy control
Marijke Becx-Bleumink
Volume:
60 - Edition:
3 -
Jul/Aug/Sep -
1992
Duration of multidrug therapy in paucibacillary leprosy patients; experience in the leprosy control program of the all africa leprosy and rehabilitation training center (ALERT) in Ethiopia
Marijke Becx-Bleumink
Volume:
60 - Edition:
2 -
Apr/May/Jun -
1992
Relapses in leprosy patients after release from dapsone monotherapy; experience in the leprosy control program of the all Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia
Marijke Becx-Bleumink
Volume:
60 - Edition:
2 -
Apr/May/Jun -
1992
Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the Leprosy Control Program of the all Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia
Marijke Becx-Bleumink1;
Debrezion Berne2
Volume:
59 - Edition:
2 -
Apr/May/Jun -
1991
Allocation of patients to paucibacillary or multibacillary drug regimens for the treatment of leprosy - a comparison of methods based mainly on skin smears as opposed to clinical methods -alternative clinical methods for classification of patients
Marijke Becx-Bleumink1
Volume:
59 - Edition:
4 -
Oct/Nov/Dec -
1991
Experience with WHO-recommended multidrug therapy (MDT) for multibacillary (MB) leprosy patients in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center in Ethiopia: appraisal of the recommended duration of MDT for MB patients
Marijke Becx-Bleumink